Nucleic Acids Research, 2004, Vol. 32, Database issue D523-D527
© 2004 Oxford University Press
RTCGD: retroviral tagged cancer gene database
Mouse Cancer Genetics Program, National Cancer Institute, Frederick, MD 21701, USA and 1 ABCC Science Applications International Corporation, Frederick, MD 21702, USA
*To whom correspondence should be addressed. Tel: +1 301 846 1260; Fax: +1 301 846 6666; Email: Copeland{at}ncifcrf.gov
Present address:
T.Suzuki, Cancer Genetics Unit, Horizontal Medical Research Organization, Kyoto University, Kyoto 606-8501, Japan
Retroviral insertional mutagenesis in mouse hematopoietic tumors provides a potent cancer gene discovery tool in the post-genome-sequence era. To manage multiple high-throughput insertional mutagenesis screening projects, we developed the Retroviral Tagged Cancer Gene Database (RTCGD; http://RTCGD.ncifcrf.gov). A sequence analysis pipeline determines the genomic position of each retroviral integration site cloned from a mouse tumor, the distance between it and the nearest candidate disease gene(s) and its orientation with respect to the candidate gene(s). The pipeline also identifies genomic regions that are targets of retroviral integration in more than one tumor (common integration sites, CISs) and are thus likely to encode a disease gene. Users can search the database using a specified gene symbol, chromosome number or tumor model to identify both CIS genes and unique viral integration sites or compare the integration sites cloned by different laboratories using different models. As a default setting, users first review the CIS Lists and then Clone Lists. CIS Lists describe CISs and their candidate disease genes along with links to other public databases and clone lists. Clone Lists describe the viral integration site clones along with the tumor model and tumor type from which they were cloned, candidate disease gene(s), genomic position and orientation of the integrated provirus with respect to the candidate gene(s). It also provides a pictorial view of the genomic location of each integration site relative to neighboring genes and markers. Researchers can identify integrations of interest and compare their results with those for multiple tumor models and tumor types using RTCGD.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Akagi, R. M. Stephens, J. Li, E. Evdokimov, M. R. Kuehn, N. Volfovsky, and D. E. Symer MouseIndelDB: a database integrating genomic indel polymorphisms that distinguish mouse strains Nucleic Acids Res., November 20, 2009; (2009) gkp1046v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Collier, D. J. Adams, C. S. Hackett, L. E. Bendzick, K. Akagi, M. N. Davies, M. D. Diers, F. J. Rodriguez, A. M. Bender, C. Tieu, et al. Whole-Body Sleeping Beauty Mutagenesis Can Cause Penetrant Leukemia/Lymphoma and Rare High-Grade Glioma without Associated Embryonic Lethality Cancer Res., November 1, 2009; 69(21): 8429 - 8437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Rasmussen, B. Wang, M. Wabl, A. L. Nielsen, and F. S. Pedersen Activation of alternative Jdp2 promoters and functional protein isoforms in T-cell lymphomas by retroviral insertion mutagenesis Nucleic Acids Res., August 1, 2009; 37(14): 4657 - 4671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Horman, C. S. Velu, A. Chaubey, T. Bourdeau, J. Zhu, W. E. Paul, B. Gebelein, and H. L. Grimes Gfi1 integrates progenitor versus granulocytic transcriptional programming Blood, May 28, 2009; 113(22): 5466 - 5475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Rahrmann, L. S. Collier, T. P. Knutson, M. E. Doyal, S. L. Kuslak, L. E. Green, R. L. Malinowski, L. Roethe, K. Akagi, M. Waknitz, et al. Identification of PDE4D as a Proliferation Promoting Factor in Prostate Cancer Using a Sleeping Beauty Transposon-Based Somatic Mutagenesis Screen Cancer Res., May 15, 2009; 69(10): 4388 - 4397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Miyazaki, N. Yamasaki, H. Oda, T. Kuwata, Y. Kanno, M. Miyazaki, Y. Komeno, J. Kitaura, Z.-i. Honda, S. Warming, et al. Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia Blood, May 7, 2009; 113(19): 4702 - 4710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bokhoven, S. L. Stephen, S. Knight, E. F. Gevers, I. C. Robinson, Y. Takeuchi, and M. K. Collins Insertional Gene Activation by Lentiviral and Gammaretroviral Vectors J. Virol., January 1, 2009; 83(1): 283 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Robbs, A. L. S. Cruz, M. B. F. Werneck, G. P. Mognol, and J. P. B. Viola Dual Roles for NFAT Transcription Factor Genes as Oncogenes and Tumor Suppressors Mol. Cell. Biol., December 1, 2008; 28(23): 7168 - 7181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kim, N. Kim, B. Dong, D. Boren, S. A. Lee, J. Das Gupta, C. Gaughan, E. A. Klein, C. Lee, R. H. Silverman, et al. Integration Site Preference of Xenotropic Murine Leukemia Virus-Related Virus, a New Human Retrovirus Associated with Prostate Cancer J. Virol., October 15, 2008; 82(20): 9964 - 9977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Newrzela, K. Cornils, Z. Li, C. Baum, M. H. Brugman, M. Hartmann, J. Meyer, S. Hartmann, M.-L. Hansmann, B. Fehse, et al. Resistance of mature T cells to oncogene transformation Blood, September 15, 2008; 112(6): 2278 - 2286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Wang, A. Garrigue, A. Ciuffi, K. Ronen, J. Leipzig, C. Berry, C. Lagresle-Peyrou, F. Benjelloun, S. Hacein-Bey-Abina, A. Fischer, et al. DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer Nucleic Acids Res., May 1, 2008; 36(9): e49 - e49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yokomizo and E. Dzierzak Fine-tuning of hematopoietic stem cell homeostasis: novel role for ubiquitin ligase Genes & Dev., April 15, 2008; 22(8): 960 - 963. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Hasemann, I. Damgaard, M. B. Schuster, K. Theilgaard-Monch, A. B. Sorensen, A. Mrsic, T. Krugers, B. Ylstra, F. S. Pedersen, C. Nerlov, et al. Mutation of C/EBP{alpha} predisposes to the development of myeloid leukemia in a retroviral insertional mutagenesis screen Blood, April 15, 2008; 111(8): 4309 - 4321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Mahale, Z. A.T. Khan, M. Igarashi, G. J. Nanjangud, R. F. Qiao, S. Yao, S. W. Lee, and S. A. Aaronson Clonal Selection in Malignant Transformation of Human Fibroblasts Transduced with Defined Cellular Oncogenes Cancer Res., March 1, 2008; 68(5): 1417 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Akimzhanov, L. Krenacs, T. Schlegel, S. Klein-Hessling, E. Bagdi, E. Stelkovics, E. Kondo, S. Chuvpilo, P. Wilke, A. Avots, et al. Epigenetic Changes and Suppression of the Nuclear Factor of Activated T Cell 1 (NFATC1) Promoter in Human Lymphomas with Defects in Immunoreceptor Signaling Am. J. Pathol., January 1, 2008; 172(1): 215 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Yang, R. R. Xian, Y. Li, T. S. Polony, and K. L. Beemon Telomerase reverse transcriptase expression elevated by avian leukosis virus integration in B cell lymphomas PNAS, November 27, 2007; 104(48): 18952 - 18957. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Guan, W.-L. Kuo, J. L. Stilwell, H. Takano, A. V. Lapuk, J. Fridlyand, J.-H. Mao, M. Yu, M. A. Miller, J. L. Santos, et al. Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer Clin. Cancer Res., October 1, 2007; 13(19): 5745 - 5755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. de Ridder, J. Kool, A. Uren, J. Bot, L. Wessels, and M. Reinders Co-occurrence analysis of insertional mutagenesis data reveals cooperating oncogenes Bioinformatics, July 1, 2007; 23(13): i133 - i141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Slape, H. Hartung, Y.-W. Lin, J. Bies, L. Wolff, and P. D. Aplan Retroviral Insertional Mutagenesis Identifies Genes that Collaborate with NUP98-HOXD13 during Leukemic Transformation Cancer Res., June 1, 2007; 67(11): 5148 - 5155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Miething, R. Grundler, C. Mugler, S. Brero, J. Hoepfl, J. Geigl, M. R. Speicher, O. Ottmann, C. Peschel, and J. Duyster Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment PNAS, March 13, 2007; 104(11): 4594 - 4599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. S. Kustikova, H. Geiger, Z. Li, M. H. Brugman, S. M. Chambers, C. A. Shaw, K. Pike-Overzet, D. d. Ridder, F. J. T. Staal, G. v. Keudell, et al. Retroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways Blood, March 1, 2007; 109(5): 1897 - 1907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rodenburg, M. Fischer, A. Engelmann, S. O. Harbers, M. Ziegler, J. Lohler, and C. Stocking Importance of Receptor Usage, Fli1 Activation, and Mouse Strain for the Stem Cell Specificity of 10A1 Murine Leukemia Virus Leukemogenicity J. Virol., January 15, 2007; 81(2): 732 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Wang, B. B. Wang, G. Bartha, L. Li, N. Channa, M. Klinger, N. Killeen, and M. Wabl Activation of an oncogenic microRNA cistron by provirus integration PNAS, December 5, 2006; 103(49): 18680 - 18684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mortellaro, R. J. Hernandez, M. M. Guerrini, F. Carlucci, A. Tabucchi, M. Ponzoni, F. Sanvito, C. Doglioni, C. D. Serio, L. Biasco, et al. Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects Blood, November 1, 2006; 108(9): 2979 - 2988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Modlich, J. Bohne, M. Schmidt, C. von Kalle, S. Knoss, A. Schambach, and C. Baum Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity Blood, October 15, 2006; 108(8): 2545 - 2553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Brown, C. R. Wilkinson, S. R. Waterman, C. H. Kok, D. G. Salerno, S. M. Diakiw, B. Reynolds, H. S. Scott, A. Tsykin, G. F. Glonek, et al. Genetic regulators of myelopoiesis and leukemic signaling identified by gene profiling and linear modeling J. Leukoc. Biol., August 1, 2006; 80(2): 433 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shou, Z. Ma, T. Lu, and B. P. Sorrentino Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapy PNAS, August 1, 2006; 103(31): 11730 - 11735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Simons, M. Pheasant, I. V. Makunin, and J. S. Mattick Transposon-free regions in mammalian genomes Genome Res., February 1, 2006; 16(2): 164 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Erkeland, R. G.W. Verhaak, P. J.M. Valk, R. Delwel, B. Lowenberg, and I. P. Touw Significance of Murine Retroviral Mutagenesis for Identification of Disease Genes in Human Acute Myeloid Leukemia Cancer Res., January 15, 2006; 66(2): 622 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Fink, R. N. Aturaliya, M. J. Davis, F. Zhang, K. Hanson, M. S. Teasdale, C. Kai, J. Kawai, P. Carninci, Y. Hayashizaki, et al. LOCATE: a mouse protein subcellular localization database Nucleic Acids Res., January 1, 2006; 34(suppl_1): D213 - D217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Duan, A. Zarebski, D. Montoya-Durango, H. L. Grimes, and M. Horwitz Gfi1 Coordinates Epigenetic Repression of p21Cip/WAF1 by Recruitment of Histone Lysine Methyltransferase G9a and Histone Deacetylase 1 Mol. Cell. Biol., December 1, 2005; 25(23): 10338 - 10351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Z. Glud, A. B. Sorensen, M. Andrulis, B. Wang, E. Kondo, R. Jessen, L. Krenacs, E. Stelkovics, M. Wabl, E. Serfling, et al. A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus Blood, November 15, 2005; 106(10): 3546 - 3552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Collier and D. A. Largaespada Hopping around the Tumor Genome: Transposons for Cancer Gene Discovery Cancer Res., November 1, 2005; 65(21): 9607 - 9610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Calmels, C. Ferguson, M. O. Laukkanen, R. Adler, M. Faulhaber, H.-J. Kim, S. Sellers, P. Hematti, M. Schmidt, C. von Kalle, et al. Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells Blood, October 1, 2005; 106(7): 2530 - 2533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Lowther, K. Wiley, G. H. Smith, and R. Callahan A New Common Integration Site, Int7, for the Mouse Mammary Tumor Virus in Mouse Mammary Tumors Identifies a Gene Whose Product Has Furin-Like and Thrombospondin-Like Sequences J. Virol., August 1, 2005; 79(15): 10093 - 10096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Modlich, O. S. Kustikova, M. Schmidt, C. Rudolph, J. Meyer, Z. Li, K. Kamino, N. von Neuhoff, B. Schlegelberger, K. Kuehlcke, et al. Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis Blood, June 1, 2005; 105(11): 4235 - 4246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Kustikova, B. Fehse, U. Modlich, M. Yang, J. Dullmann, K. Kamino, N. von Neuhoff, B. Schlegelberger, Z. Li, and C. Baum Clonal Dominance of Hematopoietic Stem Cells Triggered by Retroviral Gene Marking Science, May 20, 2005; 308(5725): 1171 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nakai, X. Wu, S. Fuess, T. A. Storm, D. Munroe, E. Montini, S. M. Burgess, M. Grompe, and M. A. Kay Large-Scale Molecular Characterization of Adeno-Associated Virus Vector Integration in Mouse Liver J. Virol., March 15, 2005; 79(6): 3606 - 3614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. De Palma, E. Montini, F. R. S. de Sio, F. Benedicenti, A. Gentile, E. Medico, and L. Naldini Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells Blood, March 15, 2005; 105(6): 2307 - 2315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Pegram, R. Pietras, A. Bajamonde, P. Klein, and G. Fyfe Targeted Therapy: Wave of the Future J. Clin. Oncol., March 10, 2005; 23(8): 1776 - 1781. [Full Text] [PDF]
|
|
|
|
|
|
A. A. Nielsen, A. B. Sorensen, J. Schmidt, and F. S. Pedersen Analysis of Wild-Type and Mutant SL3-3 Murine Leukemia Virus Insertions in the c-myc Promoter during Lymphomagenesis Reveals Target Site Hot Spots, Virus-Dependent Patterns, and Frequent Error-Prone Gap Repair J. Virol., January 1, 2005; 79(1): 67 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Frank, C. Rudolph, C. Heberlein, N. von Neuhoff, E. Schrock, A. Schambach, B. Schlegelberger, B. Fehse, W. Ostertag, C. Stocking, et al. Tumor cells escape suicide gene therapy by genetic and epigenetic instability Blood, December 1, 2004; 104(12): 3543 - 3549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jafar-Nejad and H. J. Bellen Gfi/Pag-3/Senseless Zinc Finger Proteins: a Unifying Theme? Mol. Cell. Biol., October 15, 2004; 24(20): 8803 - 8812. [Full Text] [PDF]
|
|
|
|
|
|
A. Kazanjian, D. Wallis, N. Au, R. Nigam, K. J. T. Venken, P. T. Cagle, B. F. Dickey, H. J. Bellen, C. B. Gilks, and H. L. Grimes Growth Factor Independence-1 Is Expressed in Primary Human Neuroendocrine Lung Carcinomas and Mediates the Differentiation of Murine Pulmonary Neuroendocrine Cells Cancer Res., October 1, 2004; 64(19): 6874 - 6882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Aguirre, C. Brennan, G. Bailey, R. Sinha, B. Feng, C. Leo, Y. Zhang, J. Zhang, J. D. Gans, N. Bardeesy, et al. High-resolution characterization of the pancreatic adenocarcinoma genome PNAS, June 15, 2004; 101(24): 9067 - 9072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Doan, S. D. Porter, Z. Duan, M. M. Flubacher, D. Montoya, P. N. Tsichlis, M. Horwitz, C. B. Gilks, and H. L. Grimes Targeted transcriptional repression of Gfi1 by GFI1 and GFI1B in lymphoid cells Nucleic Acids Res., May 6, 2004; 32(8): 2508 - 2519. [Abstract] [Full Text] [PDF]
|
|